Mar. 18 at 2:01 PM
$ZOMDF This is probably the strongest multi-piece setup ZOMDF has had in a long time. The company didn’t just put out one nice headline. It stacked a record Q4, a strong full year, high gross margins, very low Q4 cash burn, and then a Boehringer equine collaboration on top of that. Specifically, Zomedica reported
$10.5M Q4 2025 revenue,
$32.0M full-year 2025 revenue, 68% full-year gross margin,
$53.3M liquidity, and just
$1.1M Q4 cash burn.
$IDEX $JEPQ $TSLA $SPY ⚡️🔥💥